Generate a tailored SOP for Dr. Marco Ruella. Improve your application with a focused, well-structured draft.
Marco Ruella, MD, is an Associate Professor in the Department of Medicine, specializing in Hematology-Oncology at the University of Pennsylvania’s Perelman School of Medicine. He is a physician-scientist with a focus on immunotherapy approaches for treating hematological cancers, particularly lymphoma and leukemia. Dr. Ruella's research revolves around the mechanisms of relapse in chimeric antigen receptor T cell (CAR T) immunotherapies, where he aims to rationally design innovative combined immunotherapies for patients suffering from relapsing or refractory conditions. He obtained his medical degree with high honors from the University of Torino, Italy, and has extensive experience, including holding leadership positions in notable research laboratories and receiving multiple prestigious awards for his contributions in the field. Dr. Ruella also engages with various biotech and pharmaceutical companies as a consultant and founder of viTToria Biotherapeutics, focusing on next-generation CAR T-cell therapies. He plays a key role in academic publishing as an editor and is involved in mentoring and teaching medical residents and fellows.
University of Pennsylvania • Philadelphia, PA
Dr. Ruella serves as an Associate Professor of Medicine in Hematology-Oncology and conducts research in the area of immunotherapy.
University of Pennsylvania • Philadelphia, PA
Undertook post-doctoral research at the Center for Cellular Immunotherapies.
University of Torino • Torino, Italy
Worked as an instructor in the Biotechnology School and attended physician in Hematology.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.